Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 19 citing articles:

More Than Resveratrol: New Insights into Stilbene-Based Compounds
Paulina Pecyna, Joanna Warguła, Marek Murias, et al.
Biomolecules (2020) Vol. 10, Iss. 8, pp. 1111-1111
Open Access | Times Cited: 115
The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF
Yingying Cheng, Yuanyuan Fu, Ying Wang, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 39
Targeting regulated cell death (RCD) with small-molecule compounds in cancer therapy: A revisited review of apoptosis, autophagy-dependent cell death and necroptosis
Wei Liu, Wenke Jin, Shiou Zhu, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 2, pp. 612-625
Closed Access | Times Cited: 34
Organoid development and applications in gynecological cancers: the new stage of tumor treatment
Yang Li, Meiying Qin, Ning Liu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Small Molecular Oligopeptides Adorned with Tryptophan Residues as Potent Antitumor Agents: Design, Synthesis, Bioactivity Assay, Computational Prediction, and Experimental Validation
Hongyu Xu, Tong Li, Qi Wang, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access
Osalmid sensitizes clear cell Renal Cell Carcinoma to navitoclax through a STAT3/BCL-XL pathway
Yizheng Xue, Tianyi Chen, Z. Ma, et al.
Cancer Letters (2025) Vol. 613, pp. 217514-217514
Closed Access
Sanguinarine Inhibits Cell Growth in EBV-Positive Diffuse Large B-Cell Lymphoma
Suli Lu, Dae-jung Yang
Archivum Immunologiae et Therapiae Experimentalis (2025) Vol. 73, Iss. 1
Closed Access
Luteolin inhibits diffuse large B-cell lymphoma cell growth through the JAK2/STAT3 signaling pathway
Xin-Zhuo Zhan, Bo Yang, Yu Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Chidamide induces apoptosis in DLBCL cells by suppressing the HDACs/STAT3/Bcl‑2 pathway
Hongwei Zhang, Fenqing Chi, Keru Qin, et al.
Molecular Medicine Reports (2021) Vol. 23, Iss. 5
Open Access | Times Cited: 19
Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells
Hongtao Song, Cui Yuan, Lili Zhang, et al.
Microvascular Research (2020) Vol. 132, pp. 104060-104060
Open Access | Times Cited: 18
Protein tyrosine phosphatase PTPRO represses lung adenocarcinoma progression by inducing mitochondria-dependent apoptosis and restraining tumor metastasis
Dai Yuan, Shuangshuang Shi, Hongda Liu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Analyzing the involvement of diverse cell death-related genes in diffuse large B-cell lymphoma using bioinformatics techniques
Heyuan Feng, Xiyuan Zhang, Jian Kang
Heliyon (2024) Vol. 10, Iss. 10, pp. e30831-e30831
Open Access | Times Cited: 1
Modulating JAK2/STAT3 signaling by quercetin in Qiling Baitouweng Tang: a potential therapeutic approach for diffuse large B-cell lymphoma
Xin-Zhuo Zhan, Tian‐Hua Wei, Chen Huang, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1
Clonal hematopoiesis of indeterminate potential (CHIP): A potential contributor to lymphoma
QingQing Luo, Lili Zhou, Dong-feng Luo, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 206, pp. 104589-104589
Closed Access | Times Cited: 1
Upregulation of Actin-Related Protein 2 (ACTR2) Exacerbated the Malignancy of Diffuse Large B-Cell Lymphoma through Activating Wnt Signaling
Dandan Chen, Lili Jiang
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 5
One arrow for two targets: potential co-treatment regimens for lymphoma and HIV
Xue Chen, Lin Jia, Xiuqun Zhang, et al.
Blood Reviews (2022) Vol. 55, pp. 100965-100965
Closed Access | Times Cited: 4
Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers
Boheng Li, Qin Wan, Zhubo Li, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5147-5147
Open Access | Times Cited: 5
CSE1L Silencing Enhances Cytarabine-mediated Cytotoxicity in Acute Myeloid Leukemia
Xiaoyu Liu, Lin Yang, Kun-Ping Guan, et al.
Indian Journal of Hematology and Blood Transfusion (2024) Vol. 40, Iss. 4, pp. 629-637
Closed Access
Screening of traditional Chinese medicine monomers as ribonucleotide reductase M2 inhibitors for tumor treatment
Yaya Qin, Song Feng, Xiaodong Zhang, et al.
World Journal of Clinical Cases (2022) Vol. 10, Iss. 31, pp. 11299-11312
Open Access | Times Cited: 2
Strategies for Targeting the JAK ‐ STAT Pathway in Lymphoid Malignancies
David J. Feith, Johnson Ung, Omar Elghawy, et al.
(2023), pp. 381-401
Closed Access
Page 1

Scroll to top